As weight-loss drugs have exploded in popularity this past year, part of the craze has been members of the public wondering which celebrities are on Ozempic.

All indices such as Dow Jones, S&P 500, and Nasdaq Composite dropped by around 1% each. With that, Wall Street has extended ...

Baricitinib is under clinical development by Eli Lilly and Co and currently in Phase II for Graft Versus Host Disease (GVHD).

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...

Eli Lilly and Novo Nordisk are likely to introduce its popular injectable drugs semaglutide and tirzepatide in India in 2025.

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year.

These undervalued stocks could deliver significant growth in 2025. Analyst forecasts suggest big upside potential for these ...

The Huminsulin range is vital for managing both type 1 and type 2 diabetes, helping control blood sugar levels in adults and ...

Lupin strengthens its diabetes portfolio with the acquisition of Huminsulin products from Eli Lilly, including Insulin Human ...